Biolase Gains U.S. and International License to Presbyopia Patents

Biolase Technology, a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and related specialties, announced the signing of a fully paid license agreement related to patents owned or licensed by SurgiLight in the field of Presbyopia, which is a phenomenon of natural aging that results in the loss of near-reading ability over the age of 40 years old.

Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=81474)